Research Announcements

Guidance on Resumption of NIH Extramural Activities Following the Recent Lapse in Appropriations

Guidance on Resumption of NIH Extramural Activities Following the Recent Lapse in Appropriations


Please Post and Circulate

NIH Release Date: October 18, 2013

Distributed: October 22, 2013



The NIH has released announcement NOT-OD-14-003 to provide information to applicants and grantees about proposal and award processes that were disrupted by the partial federal government shutdown from October 1-17, 2013.


eRA Systems Availability

The Commons and other electronic NIH systems are back online as of October 18, 2013.

Rescheduling October Application Due Dates

All October due dates have been rescheduled for November. 

Funding Opportunity

Original Due Date

New Due Date

R01s, U01s (New)

October 5

November 12

Ks (New)

October 12

November 12

R03s, R21s, R34s, R36s (New)

October 16

November 18

R15s (All)

October 25

November 18

NIDCD Clinical Research Center Grant (P50) PAR-13-277

October 1

November 14

NIGMS National Centers for Systems Biology (P50) PAR-13-351

October 23

November 14

Sexually Transmitted Infections Cooperative Research Centers (U19) RFA-AI-13-043

October 23

November 14

National Cooperative Drug Discovery/Development Groups for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U19) PAR-13-086

October 24

November 14

National Cooperative Drug Discovery/Development Groups for the Treatment of Mental Disorders, Drug or Alcohol Addiction (UM1) PAR-13-087

October 24

November 14

Various RFAs, PARs, PAs

Due dates

not listed above

November  1

All November due dates will remain the same.

  • Exception:  The NIH Loan Repayment Program has been extended from November 15 to December 2

Applications Reassigned to May 2014 Council

Applications that were submitted from May – August 2013 and scheduled to be reviewed during the shutdown will be reassigned to the next cycle.


Cycle II

Cycle III

Scientific Merit Review

October – November

February – March

Advisory Council Round



Earliest Project Start Date



The NIH will email PIs whose applications are reassigned.  PIs whose applications are reassigned will be given the opportunity to “refresh” the application by:

  • Withdrawing the application by November 8, 2013
  • Resubmitting the application by November 20, 2013

Research Performance Progress Report (RPPR)

At this time, the NIH has not issued any guidance regarding non-competing progress reports due during the period the Commons was offline.

Processing Applications Submitted During the Shutdown

On a case-by-case basis, UNMC submitted a small number of NIH applications during the shutdown.  These applications should be available for viewing in the Commons from October 22-23, 2013.  If any changes need to be made to an application, it should be rejected from the Commons during this two-day viewing window.

 Award Actions

The NIH anticipates beginning to release awards after November 1, 2013.

For more information

Contact your SPAdmin Grants and Contracts Specialist

  • Attend the next SPAdmin Buzz Session at noon on Wednesday, October 23, 2013, in Room 1004 in the DRC I

Drug Discovery Seminar Kicks Off Innovations Week

UNeMed is hosting Dr. Brian Johns, Director of HIV Medicinal Chemistry at GlaxoSmithKline, on Tuesday October 8th.  He will be giving a seminar titled “Making a Difference in HIV: The Discovery & Development of Tivicay®” in the DRC1 auditorium from 10-11 on October 8th.  This seminar is meant to provide insight into the drug discovery process using their recently approved Tivicay as a case  study.  Although it is focused on an HIV drug, there will be valuable information for any researcher interested in pursuing drug discovery and drug development projects.



Information for the NIH Extramural Grantee Community During the Lapse of Federal Government Funding

Posted by on October 1st, 2013

Notice Number:  NOT-OD-13-126

The Government Fiscal Year (FY) 2013 ended on September 30, 2013 at midnight EST and an Appropriation Act for FY2014 has not been passed leading to a lapse in Federal funding. 

Issues impacting researchers are summarized below:


  • Contact with NIH Staff.  There will be no access to voice mail, e-mail, fax, or postal mail during this period
  • Submission of Grant Applications.  For the duration of the funding lapse, applicants are strongly encouraged not to submit paper or electronic grant applications to the NIH. 
  • Peer Review and Council Meetings.  NIH will not conduct initial peer review meetings or conduct Advisory Council review meetings during the lapse. 
  • eRA Commons.  eRA Commons will be unavailable during the lapse.  Submissions and progress reports cannot be accepted.
  • Awarded Grants.  No NIH awards will be processed for the duration of the funding lapse. 
  • No-Cost Extension.  No Cost Extensions cannot be submitted electronically during the lapse, grants due to expire that plan to be given a no-cost extension, will require a paper notification to the IC after operations resume.
  • HHS Payment Management System.  HHD PMS will remain open but no federal staff will be available to assist.  Grants on a reimbursement basis or other restricted funds cannot be processed during the lapse.
  • Animal Welfare.  No activities associated with the OLAW mission will continue during the funding lapse.  OLAW will extend reporting deadlines for all activities to compensate for the period of the lapse. 

The entire notice may be read at: